Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
批准号:
8539347
负责人:
YIBIN DENG
金额:
$4.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-08-31
关键词:
AccountingAddressAdvanced DevelopmentApoptosisApoptoticAutomobile DrivingBiological ModelsBreastBreast Cancer ModelBreast Cancer TreatmentBreast CarcinomaCancer PatientCell DeathChemopreventive AgentChromosomal InstabilityChromosome abnormalityChromosomesComplexDNADNA DamageDNA RepairDNA-Binding ProteinsDataDefectDevelopmentEngineeringEpithelialEpithelial CellsEpitheliumEventExperimental ModelsFunctional disorderGenesGeneticGenetic Predisposition to DiseaseGenomeGenomicsGoalsHot SpotHumanIn VitroIncidenceKnockout MiceKnowledgeLymphomaMalignant NeoplasmsMammary NeoplasmsMammary TumorigenesisMammary glandMediatingMetastatic CarcinomaMissense MutationModelingMolecularMolecular AbnormalityMolecular GeneticsMolecular TargetMusMutateMutationNeoplasm MetastasisNeoplastic Cell TransformationOncogenicPathway interactionsPharmaceutical PreparationsPlayPolymerasePrevention strategyProtein p53Research PersonnelRoleSeriesStretchingTFR2 geneTP53 geneTelomeraseTelomere ShorteningTestingTherapeutic Effectbasebreast lesionbreast tumorigenesiscancer genomecaspase-2cell transformationcohortdesigngain of functionhuman TERF2 proteinimprovedin vivoinsightmalignant breast neoplasmmouse modelmutantnew therapeutic targetnovelresearch studyresponsesarcomasoundtelomeretooltumortumor initiationtumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human sporadic breast carcinomas are characterized by the presence of complex cytogenetic aberrations. This complexity represents one of the foremost challenges for breast cancer researchers developing the experimental model systems to identify the molecular genetic etiology of breast tumor development. Our long term goal is to establish "chromosomal instability" mouse breast cancer models that recapitulate the salient features of highly rearranged and mutated human breast cancer genomes and discover the "causal" genomic events involved in mammary carcinogenesis in vivo. One important mechanism that can give rise to the unstable genome in breast cancer is the dysfunction of telomeres, the physical termini of chromosomes that protect natural chromosomal ends from being recognized as damaged DNA and inhibit inappropriate DNA repair. On the other hand, recent systematic genomic analyses in human breast carcinomas have revealed that tumor suppressor p53 is the most commonly alerted gene, predominantly through missense mutations that result in accumulation of mutant p53 protein to acquire oncogenic gain-of-function. To faithfully resemble these two important features observed in human breast carcinomas, chromosomal instability and expression of gain- of-function mutant p53, we have been engineering a novel mouse breast cancer model bearing dysfunctional telomere-induced chromosomal instability and expression of "hot spot" gain-of-function mutant p53 in breast epithelium. Our preliminary results suggest that telomere uncapping causes dysfunctional telomeres that activate DNA Damage Response (DDR)-mediated apoptotic pathway to suppress chromosomal instability- driven tumorigenesis in the absence of p53, while "hot spot" mutant p53 inhibits telomere uncapping-induced cell death and promotes cell transformation. Furthermore, we observe that mutant p53 cooperates with dysfunctional telomeres in breast epithelium to promote tumor progression to invasive breast carcinomas in vivo. In this application, we will test our hypothesis that gain-of-function mutant p53 inhibits telomere uncapping-induced DDR-mediated apoptosis to enhance chromosomal instability-driven mammary carcinogenesis in vivo. The two specific aims are designed to test the hypothesis. In Aim 1, we will generate mouse models to test the possibility that gain-of-function mutant p53 cooperates with telomere uncapping- initiated chromosomal instability to promote mammary carcinogenesis in vivo. In Aim 2, we will investigate the molecular mechanism underlying gain-of-function mutant p53 promotes chromosomal instability-driven breast tumor development. We anticipate that our engineered chromosomal instability mouse models will faithfully recapitulate the complex cytogenetic aberrations of human breast cancer and help us identify novel molecular targets to improve strategies for the prevention and treatment of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
-
批准号:10051412
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2018
-
负责人:YIBIN DENG
-
依托单位:
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
-
批准号:10307097
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2018
-
负责人:YIBIN DENG
-
依托单位:
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
-
批准号:10531862
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2018
-
负责人:YIBIN DENG
-
依托单位:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
-
批准号:8153821
-
项目类别:
-
资助金额:$30.77万
-
财政年份:2011
-
负责人:YIBIN DENG
-
依托单位:
Gain of function mutant p53 in telomere uncapping-driven breast tumorigenesis
-
批准号:8907720
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2011
-
负责人:YIBIN DENG
-
依托单位:
Prevention of PTEN deletion driven prostate cancer by selenium
-
批准号:8206703
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2010
-
负责人:YIBIN DENG
-
依托单位:
Prevention of PTEN deletion driven prostate cancer by selenium
-
批准号:8028115
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2010
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:7932617
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2009
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:7666826
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2007
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:7177883
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2007
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:7924857
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2007
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:8097439
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2007
-
负责人:YIBIN DENG
-
依托单位:
Telomere dysfunction, p53 and tumorigenesis
-
批准号:7455773
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2007
-
负责人:YIBIN DENG
-
依托单位:
海外基金